Dalia Dawoud
Biographic Data
| ID | 7893553 |
|---|---|
| NAME | Dalia Dawoud |
| GIVEN NAMES | Dalia |
| FAMILY NAME | Dawoud |
| SIGNATURE | DAWOUD D |
| AFFILIATIONS | Cairo University |
| ORCID | 0000-0002-2105-1937 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
A systematic review of economic evaluations of pharmacological treatments for active tuberculosis
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …
Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the …
Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
Patients' perspectives are important to identify preferences, estimate values and appreciate unmet medical needs in the process of research and development and subsequent assessment of new health technologies. Patient and public involvement in health technology assessment (HTA) is essential in understanding and assessing wider implications of coverage and reimbursement decisions for patients, their relatives, caregivers, and the general populatio…
Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population
Objectives: The SF-6D is a preference-based measure of health developed to generate utility values from the SF-36. The aim of this pilot study was to examine the feasibility and acceptability of using the standard gamble (SG) technique to generate preference-based values for the Arabic version of SF-6D in a Lebanese population. Methods: The SF-6D was translated into Arabic using forward and backward translations. Forty-nine states defined by the …
OP22 Projections of Healthcare Costs in the Last Year of life for Older Cancer Patients in European Union Member States (2008-2030)
Background Despite advances, cancer remains a major cause of pain, suffering and death. The highest incidence and mortality occurs in older people (≥65), and given demographic change the numbers are expected to rise in the coming years. This has financial consequences and key implications for service planning. We estimated the current and future cost of providing care for older cancer patients in the last year of life (LYOL) in the 27 European Un…
No prominent works on this page.
OP22 Projections of Healthcare Costs in the Last Year of life for Older Cancer Patients in European Union Member States (2008-2030)
Background Despite advances, cancer remains a major cause of pain, suffering and death. The highest incidence and mortality occurs in older people (≥65), and given demographic change the numbers are expected to rise in the coming years. This has financial consequences and key implications for service planning. We estimated the current and future cost of providing care for older cancer patients in the last year of life (LYOL) in the 27 European Un…
Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population
Objectives: The SF-6D is a preference-based measure of health developed to generate utility values from the SF-36. The aim of this pilot study was to examine the feasibility and acceptability of using the standard gamble (SG) technique to generate preference-based values for the Arabic version of SF-6D in a Lebanese population. Methods: The SF-6D was translated into Arabic using forward and backward translations. Forty-nine states defined by the …
Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
Patients' perspectives are important to identify preferences, estimate values and appreciate unmet medical needs in the process of research and development and subsequent assessment of new health technologies. Patient and public involvement in health technology assessment (HTA) is essential in understanding and assessing wider implications of coverage and reimbursement decisions for patients, their relatives, caregivers, and the general populatio…
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …
Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the …
A systematic review of economic evaluations of pharmacological treatments for active tuberculosis
Health Systems, Economic Evaluations, Quality of Life (5 works) · Health care (4 works) · Medicine (4 works) · Political science (4 works) · Health technology (3 works) · Public relations (3 works) · Reimbursement (3 works) · Biomedical Ethics and Regulation (2 works) · Business (2 works) · Demography (2 works)